Altamira Therapeutics's total assets for Q2 2023 were CHF6.20M, a decrease of 0.00% from the previous quarter. CYTOF total liabilities were CHF8.03M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.